SEC Comment Letter 0000000000-24-003978 to Ventyx Biosciences, Inc. (VTYX) (CIK 0001851194) (VTYX)
Ventyx Biosciences, Inc. (VTYX) (CIK 0001851194)
Date: April 12, 2024 · CIK: 0001851194 · Accession: 0000000000-24-003978
AI Filing Summary & Sentiment
File numbers found in text: 333-278584
Letter
United States securities and exchange commission logo April 12, 2024 Raju Mohan, Ph.D. Chief Executive Officer Ventyx Biosciences, Inc. 12790 El Camino Real, Suite 200 San Diego, CA 92130 Re:Ventyx Biosciences, Inc. Registration Statement on Form S-3 Filed April 9, 2024 File No. 333-278584 Dear Raju Mohan: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Robert L. Wernli, Jr.
Show Raw Text
United States securities and exchange commission logo
April 12, 2024
Raju Mohan, Ph.D.
Chief Executive Officer
Ventyx Biosciences, Inc.
12790 El Camino Real, Suite 200
San Diego, CA 92130
Re:Ventyx Biosciences, Inc.
Registration Statement on Form S-3
Filed April 9, 2024
File No. 333-278584
Dear Raju Mohan:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Robert L. Wernli, Jr.